231 related articles for article (PubMed ID: 32405780)
1. Research Progress of Drug Treatment in Novel Coronavirus Pneumonia.
Yan J; Liu A; Huang J; Wu J; Fan H
AAPS PharmSciTech; 2020 May; 21(4):130. PubMed ID: 32405780
[TBL] [Abstract][Full Text] [Related]
2. World War against COVID-19: How strong is our armamentarium?
Ramachandran V; Marimuthu RR; Chinnambedu RS
Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555
[TBL] [Abstract][Full Text] [Related]
3. Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic?
Fraser AG; SzymaĆski P; Macintyre E; Landray M
Eur Heart J; 2020 Jun; 41(23):2140-2144. PubMed ID: 32556334
[No Abstract] [Full Text] [Related]
4. Potential pharmacological agents for COVID-19.
Kotwani A; Gandra S
Indian J Public Health; 2020 Jun; 64(Supplement):S112-S116. PubMed ID: 32496239
[TBL] [Abstract][Full Text] [Related]
5. Current status of potential therapeutic candidates for the COVID-19 crisis.
Zhang J; Xie B; Hashimoto K
Brain Behav Immun; 2020 Jul; 87():59-73. PubMed ID: 32334062
[TBL] [Abstract][Full Text] [Related]
6. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
7. How likely are COVID-19 interventions to benefit the sickest patients?
Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B
Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004
[No Abstract] [Full Text] [Related]
8. COVID-19: Main therapeutic options.
Hachfi W; Ben Lasfar N
Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
[No Abstract] [Full Text] [Related]
9. Treatment of coronavirus disease 2019.
Hung IFN
Curr Opin HIV AIDS; 2020 Nov; 15(6):336-340. PubMed ID: 33002954
[TBL] [Abstract][Full Text] [Related]
10. Repurposing antimalarials and other drugs for COVID-19.
Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
[No Abstract] [Full Text] [Related]
11. Potential treatment methods targeting 2019-nCoV infection.
Zheng L; Zhang L; Huang J; Nandakumar KS; Liu S; Cheng K
Eur J Med Chem; 2020 Nov; 205():112687. PubMed ID: 32771797
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments.
Goodarzi P; Mahdavi F; Mirzaei R; Hasanvand H; Sholeh M; Zamani F; Sohrabi M; Tabibzadeh A; Jeda AS; Niya MHK; Keyvani H; Karampoor S
Int Immunopharmacol; 2020 Nov; 88():106885. PubMed ID: 32795893
[TBL] [Abstract][Full Text] [Related]
13. Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline.
Abid MA; Nunley L; Abid MB
Front Immunol; 2020; 11():1294. PubMed ID: 32582221
[No Abstract] [Full Text] [Related]
14. Recent advances of therapeutic targets and potential drugs of COVID-19.
Zhang W; Zhang P; Wang G; Cheng W; Chen J; Zhang X
Pharmazie; 2020 May; 75(5):161-163. PubMed ID: 32393419
[TBL] [Abstract][Full Text] [Related]
15. Ongoing Clinical Trials for the Management of the COVID-19 Pandemic.
Lythgoe MP; Middleton P
Trends Pharmacol Sci; 2020 Jun; 41(6):363-382. PubMed ID: 32291112
[TBL] [Abstract][Full Text] [Related]
16. Audio Interview: Capitalizing on Immune Responses to Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
[No Abstract] [Full Text] [Related]
17. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine for COVID-19: rationale, facts, hopes.
Cortegiani A; Ippolito M; Ingoglia G; Einav S
Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908
[No Abstract] [Full Text] [Related]
19. Reducing mortality from 2019-nCoV: host-directed therapies should be an option.
Zumla A; Hui DS; Azhar EI; Memish ZA; Maeurer M
Lancet; 2020 Feb; 395(10224):e35-e36. PubMed ID: 32035018
[No Abstract] [Full Text] [Related]
20. Use of convalescent plasma in COVID-19 patients in China.
Zhu M; Hu K; Zhu Z
Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
[No Abstract] [Full Text] [Related]
[Next] [New Search]